Table 3.
Days | EPG ± SD |
FECR% (day 21) |
FECR% (day 28) |
BPCR (%) | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Pre-treatment |
Post-treatment |
Methods |
Methods |
|||||||||
0 | 7 | 14 | 21 | 28 | 1 | 2 | 3 | 1 | 2 | 3 | ||
Group1 | 106.21 ± 41.19 | 42.34 ± 22.19∗ | 3.33 ± 8.77∗ | 1.53 ± 5.14∗ | 0.28 ± 1.67∗ | 98.56 | 98.56 | 98.55 | 99.73 | 99.74 | 99.73 | 97.03 |
Group 2 | 100.89 ± 45.46 | 27.69 ± 20.91∗ | 17.45 ± 17.72∗ | 1.39 ± 3.04∗ | 1.63 ± 3.87∗ | 98.69 | 98.62 | 98.61 | 98.46 | 98.38 | 98.37 | 77.66 |
Group 3 | 106.74 ± 41.02 | 101.69 ± 24.23 | 96.85 ± 20.50 | 107.14 ± 23.04 | 106.02 ± 17.76 |
The mean EPG of buffaloes from each group was counted at days 0, 7, 14, 21 and 28 after treatment. FECR% were calculated at days 21 and 28 by the three methods (Method 1 was the WAAVP method; Method 2 calculated individual buffalo reductions followed by transformation and averaging; Method 3 accounted for changes in control values over time and used group means).
Significant differences of EPG between pre-treatment and post-treatment in each group were determined using the Mann-Whitney test.
* = Significant at the 5% level (P < 0.05).